Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

How AI Predicts Drug Failure Before Human Trials

1Why Predicting Drug Failure Matters2What AI Learns From: The Data Behind Predictions3How AI Turns Data Into a Failure Prediction4Judging Whether a Prediction Can Be Trusted5How Predictions Are Used in Real Drug Development
How AI Turns Data Into a Failure Prediction

Why a High Score Is Not a Verdict

3 / 3
Think about two drugs sitting at exactly the same point on the risk scale. The model cannot tell them apart, because at the level of the properties it was given, they are the same. Yet one may fail and the other may reach patients. The deciding difference is something the model was never shown: how the drug behaves in a particular patient group, how it interacts with another treatment, whether the trial was designed well enough to detect an effect. So a high score is a reason to look harder at a candidate, not a reason to drop it. It shifts attention rather than settling the question.
0:00 / 0:00

The model's output is a position on a scale, and positions are shared. Any number of candidates can occupy the same position, and nothing in the model's output distinguishes them from one another. The differences that decide their real fates are differences the model was not given.

A high score is a reason to scrutinize a candidate more closely, not a reason to abandon it. A low score is a reason for ordinary confidence, not a guarantee. In both directions the score shifts attention; it does not settle the question.

The properties a model receives are a compressed description of the drug and its context. Patient population, concurrent treatments, and trial design are examples of real influences that may simply not be represented in that description.

Previous3 / 3Next

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion